Topoisomerase Inhibitors in Metastatic Breast Cancer: Overview of Current Practice and Future Development

Auteurs : Vanderbeeken MC, Aftimos P, Awada A
Année : 2013
Journal : Current Breast Cancer Rep
Volume : 5
Pages : 31-41

Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.

Auteurs : Awada A, Vandone AM, Aftimos P
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(3)
Pages : 297-304

Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: what next?

Auteurs : Aftimos P, Awada A
Année : 2011
Journal : Adv Ther
Volume : 28(11)
Pages : 973-85

mTor inhibition in RCC: proof of concept, clinical use, and future directions,

Auteurs : Aftimos P, Awada A, Gil T
Année : 2011
Journal : Belgian J Medical Oncology
Volume : 5(5)
Pages : 205-11